The scholarly study.

The development of interferon-free treatments has been a tremendous step forward in the typical of care, said business lead writer Andrew Muir, MD, MHS, in a news release. These medicines are highly effective and well […]

Pablo Lapuerta.

The number needed to treat would probably be lower for a patient people at higher gastrointestinal risk than our research population. Newer, stronger antiplatelet agents are getting into the clinical arena.35-40 Nevertheless, research into clopidogrel […]

Lisa Rosenbaum.

Lisa Rosenbaum, M edpillsotc.com .D.: Transitional Chaos or Enduring Damage? The EHR and the Disruption of Medicine A decade ago, a primary care physician I undone admired seemed to come. His effectiveness had derived not […]

In an interview with ABC News.

Some patients are reading through to their medications on the web always, and it appears they only browse the negative rather than the positive. Dr. Honaker’s disdain for discriminating patients was echoed throughout the news […]

Short-term disability.

Alere director to analyze worth of worksite health programs at 28th SALGBA conference The importance of measuring productivity, short-term disability, workers’ comp and job satisfaction when analyzing the value of worksite health programs would be […]

Michael Felker.

McNulty, M.S., Eric J. Velazquez, M.D., Jenny C. Ibarra, R.N., M.S.N., Alice M. Mascette, M.D., and Eugene Braunwald, M.D. For the Heart Failure Clinical Research Network: Ultrafiltration in Decompensated Center Failure with Cardiorenal Syndrome The […]

AccuVein announces $22.

Bednarski, partner at MVM. Christopher Gabrieli, partner at Bessemer, added, ‘AccuVein is rolling out a unique, innovative product with potential in multiple marketplaces. We look forward to working with Ron and the team as they […]

Page 1 of 3123